TW
BIIB icon

Transform Wealth’s Biogen BIIB Stock Holding History

Transform Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,431
Closed -$3.17M – 232
2019
Q1 		$3.17M Buy
13,431
+5,496
+69% +$1.73M 0.59% 68
2018
Q4 		$2.39M Buy
7,935
+7,305
+1,160% +$2.33M 0.49% 73
2018
Q3 		$223K Sell
630
-639
-50% -$220K 0.04% 179
2018
Q2 		$368K Buy
1,269
+367
+41% +$103K 0.07% 173
2018
Q1 		$247K Sell
902
-4,761
-84% -$1.48M 0.05% 215
2017
Q4 		$1.8M Buy
5,663
+388
+7% +$124K 0.33% 97
2017
Q3 		$1.65M Buy
5,275
+61
+1% +$18.1K 0.58% 50
2017
Q2 		$1.42M Buy
5,214
+1,252
+32% +$331K 1.6% 19
2017
Q1 		$1.08M Buy
3,962
+306
+8% +$86.5K 0.41% 85
2016
Q4 		$1.04M Buy
+3,656
New +$1.08M 0.41% 81

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Transform Wealth's BIIB Position: Q2 2019 in Review

Transform Wealth sold out of Biogen (BIIB) in Q2 2019, closing a stake of 13,431 shares — an estimated $3.17M sold.

Transform Wealth first reported a position in BIIB in Q4 2016 and held it in 10 quarters. The position peaked at $3.17M in Q1 2019. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Transform Wealth reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Transform Wealth sold 13,431 Biogen shares in Q2 2019, an estimated $3.17M.
  • Transform Wealth first reported a position in Biogen in Q4 2016 and held it in 10 quarters.
  • Transform Wealth's Biogen position peaked at $3.17M in Q1 2019.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Transform Wealth's 13F filing for Q2 2019, filed 30 Jul 2019.